Research Project

Project Title:

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy (APPEAR)

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Immune glomerulopathies

Project Summary:

The study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy.

Lead principal investigator(s):



Erica Daina, Bergamo

Project Period:

07/2021   -   08/2023

« Back to research page